Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

STERIS plc STE

Healthcare  —  Medical Devices
208.93 0.16 0.08% as of 25 Sep
Market cap
$20.4B
P/E
25.4×
S&P 500 Member Dividend Champion (10y) Cash Flow Champion (3y) Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

STERIS plc (STE) EV/EBITDA

As of 25 September 2026, STERIS plc (STE) trades at a EV/EBITDA of 13.4×. Over the past ten years it has ranged from 13.1× (August 2015) to 33.5× (August 2021); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 14.6× (18.99%)
FY2025 18.0× 2.11%
FY2024 17.7× 8.79%
FY2023 16.2× (32.29%)
FY2022 24.0× 4.10%
FY2021 23.0× 33.01%
FY2020 17.3× (6.04%)
FY2019 18.4× 20.38%
FY2018 15.3× 1.48%
FY2017 15.1× (15.14%)

Quarterly

Period EV/EBITDA Change
Jun 2026 13.5× (7.93%)
Mar 2026 14.6× (18.02%)
Dec 2025 17.8× 0.06%
Sep 2025 17.8× (1.06%)
42 more quarters

Against its own ten years

Low 13.1× High 33.5×
Ten-year median 17.8×
Current reading's percentile 1

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 5.7×
PHG Koninklijke Philips N.V. compare 8.6×
ZBH Zimmer Biomet Holdings, Inc. compare 10.6×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc 13.4×
DXCM DexCom, Inc. compare 23.2×
PEN Penumbra, Inc. compare 58.2×
BIO.B Bio-Rad Laboratories, Inc. compare 176×
BIO Bio-Rad Laboratories, Inc. compare 184×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on STE